The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2
Author/s
author: Rahul Suryawanshi, Galen J Correy, Moira M Rachman, Patrick C O'Leary, Taha Y Taha, Yusuke Matsui, Francisco José Zapatero-Belinchón, Yagmur Umay Doruk, Morgan E. Diolaiti, Hua-Dong Chen, Alicia L Richards, Mauricio Montano, Julia Rosecrans, Michael Matthay, R. Jeffrey Neitz, Nevan Krogan, Danielle L Swaney, Brian K. Shoichet, Melanie Ott, Adam R Renslo, Alan Ashworth, James S Fraser
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.